Retatrutide Weight Loss by Gender
Men and women lose weight differently -- different rates, different patterns, different body regions. Here is how gender influences retatrutide results and why percentage matters more than pounds.
The question "do men lose more weight on retatrutide?" has a nuanced answer. In absolute pounds, typically yes -- men start heavier and have higher metabolic rates. But in percentage terms, the difference narrows substantially. Phase 2 data (Jastreboff et al., NEJM 2023) showed significant weight loss in both men and women, with both groups achieving the transformative results that make retatrutide unique among weight loss medications.
Data Context
Gender-stratified results from Phase 2 are limited. Phase 3 trials with larger enrollment will provide more detailed gender-based analysis. Retatrutide is investigational.
Why Men Often Lose Faster Initially
Men typically have 10-15% more muscle mass than women at the same body weight. Muscle is metabolically active tissue that burns calories at rest. This higher basal metabolic rate means men start with a larger caloric deficit when appetite is suppressed by the same amount. Additionally, men tend to carry more visceral fat, which is mobilized more readily during weight loss than subcutaneous fat. Finally, men do not experience the monthly hormonal fluctuations that cause water retention variations in premenopausal women.
Why Percentage Results Converge
Over the full 48-week treatment period, percentage weight loss between men and women tends to converge. The initial speed advantage men have is offset by several factors: women's bodies become more metabolically efficient as they lose weight, hormonal influences on fat distribution change with significant weight loss, and the appetite-suppressing effects of triple agonism are comparable between genders.
Gender-Specific Considerations
For Women
- Track weight as a 4-week average to smooth out menstrual cycle fluctuations
- Weight loss may restore ovulatory cycles -- discuss contraception if relevant
- PCOS symptoms (irregular periods, acne, hirsutism) often improve dramatically with weight loss
- Bone density monitoring may be appropriate for postmenopausal women losing significant weight
For Men
- Testosterone levels typically improve with weight loss, enhancing muscle preservation
- Sleep apnea resolution rates are particularly high in men who lose 20%+ body weight
- Erectile dysfunction often improves with weight loss and improved cardiovascular health
- Higher caloric needs may make protein targets easier to meet despite appetite suppression
To start your weight loss journey, visit our treatments page.
Medical Disclaimer
This article is for educational purposes only. Retatrutide is not FDA-approved. Gender-specific outcomes are estimates. Clinical data from Phase 2 (Jastreboff et al., NEJM 2023). Consult a healthcare provider.
Effective for Men and Women
Start today. Semaglutide from $99/mo, tirzepatide from $125/mo.
Get Started TodayMore on Retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).